Mental Health DailyResearch. Evidence. Perspective.Published research on viibryd.
Viibryd (Vilazodone) is a drug that was developed by Merck for the treatment of clinical depression. It was approved in the United States as an antidepressant medication in 2011. It function…
Read articleWhen a new antidepressant drug is released, everyone wants to be the first to try it. In most cases, people seem to always believe that newer will equal better in terms of depression relief.…
Read articleThe popularity of antidepressants has changed significantly over time. The first antidepressants called MAOIs were discovered in the 1950s and instantly became the most popular class. As new…
Read articleAtypical antidepressants are unique from other classes of antidepressants based on pharmacological properties. These days, the most common antidepressants fit into one of a few categories: S…
Read articleApproximately 1 out of 4 people that take antidepressants experience weight gain as a side effect. The weight gain may be minor, but over time, gaining a pound here and there all adds up. Ma…
Read articleViibryd (Vilazodone) is a relatively popular new antidepressant that has been found effective for treating symptoms of major depression. Many people have had success with this antidepressant…
Read article